UPDATE 1-Bayer gains full Vitrakvi rights from Eli Lilly's Loxo
February 15, 2019 at 11:33 AM EST
* Bayer gains full control over drug Vitrakvi (larotrectinib)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|